The Pennant Group, Inc. (NASDAQ:PNTG) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of The Pennant Group, Inc. (NASDAQ:PNTG) have earned an average rating of “Hold” from the five brokerages that are covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $33.50.

A number of equities analysts have issued reports on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of The Pennant Group in a report on Tuesday, October 14th. Wall Street Zen downgraded The Pennant Group from a “buy” rating to a “hold” rating in a report on Friday, September 26th. Truist Financial lowered their target price on The Pennant Group from $32.00 to $28.00 and set a “hold” rating for the company in a research report on Wednesday, July 16th. Stephens reaffirmed an “overweight” rating and issued a $40.00 price objective on shares of The Pennant Group in a research note on Thursday, October 9th. Finally, Wells Fargo & Company decreased their target price on shares of The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating for the company in a research report on Thursday, August 14th.

Hedge Funds Weigh In On The Pennant Group

Hedge funds and other institutional investors have recently modified their holdings of the business. Ranger Investment Management L.P. grew its stake in shares of The Pennant Group by 56.6% during the 2nd quarter. Ranger Investment Management L.P. now owns 304,925 shares of the company’s stock worth $9,102,000 after acquiring an additional 110,175 shares during the period. CANADA LIFE ASSURANCE Co boosted its holdings in shares of The Pennant Group by 31.5% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 13,361 shares of the company’s stock worth $399,000 after purchasing an additional 3,197 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of The Pennant Group by 161.6% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,987 shares of the company’s stock worth $119,000 after acquiring an additional 2,463 shares during the last quarter. Lazard Asset Management LLC grew its stake in shares of The Pennant Group by 539.0% during the second quarter. Lazard Asset Management LLC now owns 54,888 shares of the company’s stock valued at $1,637,000 after buying an additional 46,298 shares during the last quarter. Finally, BNP Paribas Financial Markets lifted its position in The Pennant Group by 21.7% in the second quarter. BNP Paribas Financial Markets now owns 97,286 shares of the company’s stock valued at $2,904,000 after purchasing an additional 17,324 shares during the last quarter. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Stock Performance

NASDAQ PNTG opened at $24.98 on Thursday. The firm has a 50-day moving average price of $24.71 and a two-hundred day moving average price of $25.84. The Pennant Group has a 12-month low of $21.18 and a 12-month high of $34.82. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $863.31 million, a P/E ratio of 32.03, a P/E/G ratio of 2.03 and a beta of 1.35.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.